What the experts are saying about PJC.A-T

He does not hold because of valuation and that the sector is one that he does not need to be in. If you are sitting on gains, there is nothing wrong with taking them. It may go up because of share buybacks, however.

He does not hold because of valuation and that the sector is one that he does not need to be in. If you are sitting on gains, there is nothing wrong with taking them. It may go up because of share buybacks, however.

Operates pharmacies primarily in Québec. He likes the space and it does meet his criteria. Their cash ROE is just shy of 30%, and their cash ROE/PE metric is about 2.67. Based on those metrics, this would be a good one to own.

Operates pharmacies primarily in Québec. He likes the space and it does meet his criteria. Their cash ROE is just shy of 30%, and their cash ROE/PE metric is about 2.67. Based on those metrics, this would be a good one to own.

In retail, he would be looking at off-price retail or convenience. Alimentation Couch-Tard (ATD.B-T) is one. Jean Coutu is down about 10%-11% from its highs and is underperforming the group. Likes the consumer, but wants to own one that has a bit of a tailwind.

In retail, he would be looking at off-price retail or convenience. Alimentation Couch-Tard (ATD.B-T) is one. Jean Coutu is down about 10%-11% from its highs and is underperforming the group. Likes the consumer, but wants to own one that has a bit of a tailwind.

He does not know the seasonality on this one. The chart is not so good. The stock is in a downward trend and may be trying to find support above $18. It is underperforming the market, below the 20 day moving average, and the momentum indicators are on the downside. There is insufficient reason to buy at these levels. Watch it to see if it bottoms.

He does not know the seasonality on this one. The chart is not so good. The stock is in a downward trend and may be trying to find support above $18. It is underperforming the market, below the 20 day moving average, and the momentum indicators are on the downside. There is insufficient reason to buy at these levels. Watch it to see if it bottoms.

The seasonality on this tends to positive in the summer. The stock tends to peak out around the middle of September, so we are getting close to the end of a period of seasonal strength. Technically the trend is down, but seems to be trying to form a base. Trading below its 20 day moving average which is not so good. Short-term momentum indicators are slightly positive. The time to take profits is probably from the middle to the end of September.

The seasonality on this tends to positive in the summer. The stock tends to peak out around the middle of September, so we are getting close to the end of a period of seasonal strength. Technically the trend is down, but seems to be trying to form a base. Trading below its 20 day moving average which is not so good. Short-term momentum indicators are slightly positive. The time to take profits is probably from the middle to the end of September.

In the downturn this stock most definitely took out its past lows. Had been making a higher lows and higher highs and the last low of around $24 definitely broke. It may be starting to put in a base, but he would like to see it bounce around a bit and find support at around $19 before buying.

In the downturn this stock most definitely took out its past lows. Had been making a higher lows and higher highs and the last low of around $24 definitely broke. It may be starting to put in a base, but he would like to see it bounce around a bit and find support at around $19 before buying.

This has been under pressure because of declining generic drug prices. Pays a decent dividend and, on a valuation basis, this is a good entry point. Likes their franchise model, which means their CapX is much lower than if they were corporately owned. About 95% of the stores are franchised, so there is a reoccurring revenue stream with not a lot of capital tied up.

This has been under pressure because of declining generic drug prices. Pays a decent dividend and, on a valuation basis, this is a good entry point. Likes their franchise model, which means their CapX is much lower than if they were corporately owned. About 95% of the stores are franchised, so there is a reoccurring revenue stream with not a lot of capital tied up.

Kind of a Shoppers Drug Mart of Québec, and has a dominant position there. Stumbled very badly a few years ago making US acquisitions, but are now doing better. Has pretty much has recovered from its woes of the past. This is worth a look.

Kind of a Shoppers Drug Mart of Québec, and has a dominant position there. Stumbled very badly a few years ago making US acquisitions, but are now doing better. Has pretty much has recovered from its woes of the past. This is worth a look.

This stock has done fabulously well. They made all of these acquisitions. The stock has, fairly far, outrun its FMV because of their tremendous momentum with acquisitions. He is not surprised that the stock is setting back. It is historically high and also high against all of his parameters too. It is expensive.

This stock has done fabulously well. They made all of these acquisitions. The stock has, fairly far, outrun its FMV because of their tremendous momentum with acquisitions. He is not surprised that the stock is setting back. It is historically high and also high against all of his parameters too. It is expensive.

Thinks they are driven by money coming out of SC-T when it was acquired. They increased the dividend and this is driving the stock. They are now more shareholder friendly. Doesn’t think it will be sold in our lifetime.

Thinks they are driven by money coming out of SC-T when it was acquired. They increased the dividend and this is driving the stock. They are now more shareholder friendly. Doesn’t think it will be sold in our lifetime.

There is consolidation in this industry. The family would have to want to sell in the case of being acquired. Likes the pharma industry, which is more attractive than grocery. The chart is not that attractive so she would wait for it to pull back a little bit.

There is consolidation in this industry. The family would have to want to sell in the case of being acquired. Likes the pharma industry, which is more attractive than grocery. The chart is not that attractive so she would wait for it to pull back a little bit.

Recently did a big dividend distribution. Looks like a decent play. Valuation looks a little bit stretched. If you want a play in this space, he would look at Loblaw’s (L-T) or Empire (EMP.A-T), which is very interesting if you look a year out from now.

Recently did a big dividend distribution. Looks like a decent play. Valuation looks a little bit stretched. If you want a play in this space, he would look at Loblaw’s (L-T) or Empire (EMP.A-T), which is very interesting if you look a year out from now.

(Market call minute.) A lots of speculation around this in terms of whether Metro (MRU-T) is going to buy it. Trades at a rich multiple but is executing quite well and generating a ton of free cash flow. Very, very safe dividend.

(Market call minute.) A lots of speculation around this in terms of whether Metro (MRU-T) is going to buy it. Trades at a rich multiple but is executing quite well and generating a ton of free cash flow. Very, very safe dividend.

Recently made an offer to buy back shares at $18.50 and if you own, he would be tempted to take it. Also paying a special dividend. He would expect that after the dividend and the buy back the stock will trade a little bit lower. There is a lot of competition coming, especially in the front end of the store. A little expensive right now but could be very interesting a few dollars down.

Recently made an offer to buy back shares at $18.50 and if you own, he would be tempted to take it. Also paying a special dividend. He would expect that after the dividend and the buy back the stock will trade a little bit lower. There is a lot of competition coming, especially in the front end of the store. A little expensive right now but could be very interesting a few dollars down.

One of the few companies who have invested in the drug store space. Was going to move his money from Shoppers. But if you are buying it for them to be taken out then you could be waiting a long time. A great space and there is room to grow the dividend.

One of the few companies who have invested in the drug store space. Was going to move his money from Shoppers. But if you are buying it for them to be taken out then you could be waiting a long time. A great space and there is room to grow the dividend.

The longer-term trend is with you. The stock periodically does a little bit of consolidation. Chart shows higher highs and higher lows, which is a healthy profile. Right now it is in a consolidation phase and if it got to the trend line at about $17, it would be a buying opportunity. Great-looking chart.

The longer-term trend is with you. The stock periodically does a little bit of consolidation. Chart shows higher highs and higher lows, which is a healthy profile. Right now it is in a consolidation phase and if it got to the trend line at about $17, it would be a buying opportunity. Great-looking chart.

Potential take out candidate. It would be Metro, most likely. A very well run company. With shippers taken out it will be the only guy left. The take out premium has already been priced in. He would wait. Doesn’t like the risk / reward ratio. It would make a lot of sense if PJC took out someone else.

Potential take out candidate. It would be Metro, most likely. A very well run company. With shippers taken out it will be the only guy left. The take out premium has already been priced in. He would wait. Doesn’t like the risk / reward ratio. It would make a lot of sense if PJC took out someone else.

What is interesting about this is that they sold Rite Ade recently so they have about $500 million in cash. Then you have the Loblaw’s (L-T) and Sobeys’s, Safeway. Metro is saying they could do something maybe. He thinks it is possible that Metro can buy this company. He would not want to buy something just for that though. This one is on his watch list for $17.50.

What is interesting about this is that they sold Rite Ade recently so they have about $500 million in cash. Then you have the Loblaw’s (L-T) and Sobeys’s, Safeway. Metro is saying they could do something maybe. He thinks it is possible that Metro can buy this company. He would not want to buy something just for that though. This one is on his watch list for $17.50.

This one had a big jump on the news of the Shoppers takeover. Not sure how much more upside there is on this. Getting to the point where he is going to have to start thinking about selling. They still own a lot of shares in Rite Aid (RAD-N).

This one had a big jump on the news of the Shoppers takeover. Not sure how much more upside there is on this. Getting to the point where he is going to have to start thinking about selling. They still own a lot of shares in Rite Aid (RAD-N).

(A Top Pick Nov 15/11. Up 16.22%.) Sold his holdings in August for gain of over 30% from his original cost price. Felt that for the time being consumer staples were not going to do as well but since then some of them are starting to look interesting. If you own, continue to Hold. $14.50 would be an ideal entry point.

(A Top Pick Nov 15/11. Up 16.22%.) Sold his holdings in August for gain of over 30% from his original cost price. Felt that for the time being consumer staples were not going to do as well but since then some of them are starting to look interesting. If you own, continue to Hold. $14.50 would be an ideal entry point.

Drugstore chain, primarily in Québec and New Brunswick. Had some issues where they had bought some Rite Aid stores and are getting this sorted out. Expect the cash they get from selling these will be used for a domestic acquisition. Managing the balance sheet well. Very undervalued.

Drugstore chain, primarily in Québec and New Brunswick. Had some issues where they had bought some Rite Aid stores and are getting this sorted out. Expect the cash they get from selling these will be used for a domestic acquisition. Managing the balance sheet well. Very undervalued.

Had a strong quarterly report and are in a strong long-term trend. He would put a Stop in at around $13.75. They're in the right space in Consumer Staples, which is strong in Canada and the US on a monthly and weekly basis.

Had a strong quarterly report and are in a strong long-term trend. He would put a Stop in at around $13.75. They're in the right space in Consumer Staples, which is strong in Canada and the US on a monthly and weekly basis.

It never hurts to take profits when you have them. IN the drug retail trade, Alberta is going to review their drug reimbursement as did Ontario in the past. But this one has things going well, same store sales going up. They have retrenched from the bad experience in the US and done better. Multiples are not that huge. If you are really long term focused, they will do ok, but after this run he would be tempted to take profits.

It never hurts to take profits when you have them. IN the drug retail trade, Alberta is going to review their drug reimbursement as did Ontario in the past. But this one has things going well, same store sales going up. They have retrenched from the bad experience in the US and done better. Multiples are not that huge. If you are really long term focused, they will do ok, but after this run he would be tempted to take profits.

Has gone a long way to straightening out some of the difficulties they were having in the US. Still own a little bit of Rite Aid but have been fixing in terms of monetizing in order to reduce their exposure. All the alien drug companies have been faced with provinces’ handling of generic drugs. Last quarter was a little bit weak. Same-store sales were okay but margins on some of the sundry items were not as high as he would have liked. This is reflective of the competitive environment out there. He would prefer Shoppers (SC-T).

Has gone a long way to straightening out some of the difficulties they were having in the US. Still own a little bit of Rite Aid but have been fixing in terms of monetizing in order to reduce their exposure. All the alien drug companies have been faced with provinces’ handling of generic drugs. Last quarter was a little bit weak. Same-store sales were okay but margins on some of the sundry items were not as high as he would have liked. This is reflective of the competitive environment out there. He would prefer Shoppers (SC-T).